SERUM URIC acid levels in the high-normal range are associated with reduced renal function in patients with type 1 diabetes, according to researchers.

The FDA has cleared NovoLog (insulin aspart [rDNA origin] injection) from Novo Nordisk for continuous subcutaneous insulin infusion (CSII) by external insulin pump in pediatric patients aged 4-18 years.

Abbott Pharmaceuticals' FreeStyle Navigator Continuous Glucose Monitoring System, which provides minute-by-minute information about the rate and direction of changes in blood sugar levels, has been approved for diabetics.

The FDA issued a communication on March 27 about its ongoing safety review of Regranex (becaplermin gel, Ortho-McNeil), a topical medicine applied directly to the foot and leg ulcers of patients with diabetes.

The FDA has approved Welchol (colesevelam hydrochloride) to reduce blood glucose in adults with type 2 diabetes mellitus in combination with metformin, sulfonylureas, or insulin, either alone or in combination with other agents, according to Daiichi Sankyo, Inc., of Parsippany, N.J.

SERUM URIC acid levels in the high-normal range are associated with reduced renal function in patients with type 1 diabetes, according to researchers.

Older individuals suffering from complications of type 2 diabetes are at increased risk of falling, researchers found.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

Depomed, Inc., of Menlo Park, Calif., has received approval for 1,000-mg strength tablets of Glumetza (metformin hydrochloride extended-release tablets), which is indicated alone or in combination with a sulfonylurea or insulin as an adjunctive therapy to improve glycemic control in adult type 2 diabetes patients.

DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.